Navigation Links
Sentry BioPharma Services Earns a GSA Federal Supply Schedule Contract #GS-10F-0432X
Date:10/18/2011

INDIANAPOLIS, Ind., Oct. 18, 2011 /PRNewswire/ -- Sentry BioPharma Services, a provider of global biopharmaceutical cGMP storage, supply chain management, prescription drug distribution and clinical packaging services, announced today that they have signed a five-year contract with the General Service Administration for inclusion on the Federal Supply Schedule, Logistics Worldwide (LogWorld). Inclusion on this schedule will help Sentry BioPharma secure no bid contracts with many federal government agencies for the provision of temperature-controlled storage and distribution of vaccines and pharmaceutical products.

(Logo: http://photos.prnewswire.com/prnh/20111018/DE87636LOGO)

When asked about the significance of this contract, Ms. Jennifer Marcum, Sentry's CEO, stated that "earning a GSA Contract is not only a testament to Sentry BioPharma's expertise as a biopharmaceutical warehousing and logistics provider and its ability to expeditiously implement key projects.  It is also a validation of our international services, as the application process includes an extensive review of Sentry's prior experience with temperature-controlled vaccine and pharmaceutical storage and logistics, as well as a survey of our clients' satisfaction with our company." Marcum further elaborated by stating that "Sentry's biopharmaceutical storage and drug distribution services are perfectly designed and constructed to support any government agency's needs for the cGMP storage, labeling, kitting and distribution of temperature-sensitive pharmaceutical products, including vaccines and regulated medications." Finally, Marcum stressed that "by investing the resources to complete the GSA contracting process, Sentry expects to gain efficiencies when contracting with federal agencies like Department of Defense (DOD), the Centers for Disease Control and Prevention (CDC) and the Department of Veterans Affairs (VA)."  Additional information regarding Sentry's GSA Contract can be found at GSA eLibrary.

About Sentry BioPharma Services

Sentry BioPharma Services maintains cGMP temperature-controlled storage for vaccine and other biopharmaceutical product, FDA labeling capability, drug distribution licenses and an active Foreign Trade Zone status to exclusively serve the global pharmaceutical, biotechnology and health care industries. Its facilities, infrastructure and services are specifically designed to meet the cGMP warehousing, packaging, cold chain logistics and contract service needs of pharmaceutical and biotech firms, health care providers and suppliers, contract research organizations (CROs), contract manufacturing organizations (CMOs), wholesalers, distributors and government entities.

Sentry's management team offers expertise in pharmaceutical cold chain storage and logistics, quality assurance, biopharmaceutical packaging and kitting development. Sentry also offers strategic solutions for global transportation and logistics, as well as end-to-end import and export management.

The company's validated processes and inventory tracking systems are FDA compliant, adhere to current Good Manufacturing Practices (cGMPs) and comply with stringent standard operating procedures (SOPs) outlined in Sentry's Validation Master Plan. Sentry is VAWD® accredited, which ensures its storage, handling and distribution methods meet the recognized guidelines of the National Association of Boards of Pharmacy®. The company is privately held and strategically headquartered in Indianapolis, Indiana.

Media Contact:
Ms. April L. Lentz
Sentry BioPharma Services, Inc.
Phone: (866) 757-7400 ext. 107
Email: info@sentrybps.com
Website: www.sentrybps.com


'/>"/>
SOURCE Sentry BioPharma Services, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Genesis Biopharma Signs Worldwide License Agreement with the NIH for Adoptive Cell Therapy to Treat a Variety of Cancers
2. Inspiration Biopharmaceuticals Names John P. Butler Chief Executive Officer
3. CoLucid Pharmaceuticals to Present at Sofinnova Japan Biopharma Partnering Conference on Tuesday, October 4th in Tokyo, Japan
4. Experts to Provide Successful Strategies for Global Biopharmaceutical Development and Commercialization at PAREXEL Tokyo Seminar
5. Regado Biosciences, Inc. to Present at the Sofinnova Japan Biopharma Partnering Conference in Tokyo, Japan
6. Global Protein Purification Reagents Market: An Expanding Role in Biopharmaceutical; Diagnostics; and Basic Biomedical Research
7. Research Demonstrates Possible Michigan Job Losses from Sectors Supported by Biopharmaceutical Companies
8. Research Demonstrates Possible Ohio Job Losses from Sectors Supported by Biopharmaceutical Companies
9. Research Demonstrates Possible Texas Job Losses from Sectors Supported by Biopharmaceutical Companies
10. CMC Biologics Enters Commercial Supply Agreement with Inspiration Biopharmaceuticals for IB1001
11. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/18/2017)... DUBLIN , Feb. 17, 2017 Research and ... Business Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... Europe , Asia-Pacific , Latin America ... for the period 2015 through 2022. Also, a six-year historic analysis is ...
(Date:2/17/2017)... According to a new market research report "Particle Counters ... Monitoring, Contamination Monitoring of Liquids), and End User (Healthcare Industry, Semiconductor ... is expected to reach USD 330.6 Million by 2021 from USD ... to 2021. Continue Reading ... ...
(Date:2/17/2017)... Feb 17, 2017 Research and Markets has announced ... Report" report to their offering. ... The report provides separate comprehensive analytics for the US, ... , Asia-Pacific , and Rest of World. Annual estimates ... six-year historic analysis is provided for these markets. Market data and analytics ...
Breaking Medicine Technology:
(Date:2/16/2017)... ... February 17, 2017 , ... Teaching nursing care of vulnerable children is the ... (pediatrics) is being created with the support of the Hearst Foundations. An initiative of ... will address what has been identified as a critical gap in preparing the next ...
(Date:2/16/2017)... ... February 16, 2017 , ... As a reflection of ... care, NWH has achieved Magnet® recognition for the second time, announced ... The American Nurses Credentialing Center’s Magnet Recognition Program® distinguishes organizations that meet rigorous ...
(Date:2/16/2017)... ... February 16, 2017 , ... PRESS RELEASE, FOR ... , David A Doege is excited to announce the launch of Doege ... up new builds, design build, and site improvements. , Mr. Doege says, "I ...
(Date:2/16/2017)... ... 16, 2017 , ... A February 6 article on World Health.net ... noting that some 425,000 procedures were performed with the new technology in 2015. ... fact, seeing a great deal of interest from area patients who are seeking out ...
(Date:2/16/2017)... ... 2017 , ... Anahata Ananda of Shamangelic Healing, Sedona ... healing and society on the widely followed Aubrey Marcus Podcast in Austin, TX. ... many, the challenges facing them today can be daunting. In this episode, "Healing ...
Breaking Medicine News(10 mins):